Obesity and hypoglycaemia in type 2 diabetes mellitus outpatients on insulin therapy in Nigeria–data from the multicentre evaluation of type 2 diabetes mellitus outpatients patients on insulin therapy (METOIN) study.

Authors

  • M. O. Nkpozi
  • I. O. Mbah
  • G. E. Bozimo
  • K. Akhidue
  • C. M. Ezeude
  • S. U. Ogbonna
  • F. A. Owolabi

Abstract

Background and Objective: Despite the obvious benefits of early insulin use in
achieving good glycaemic control, insulin linked overweight/obesity and
hypoglycaemia are sources of concern and worry. Burden of these side effects among
type 2 diabetes mellitus (T2DM) outpatients on insulin therapy in Nigeria is
unknown.
Subjects and Methods: This was a prospective, cross sectional and observational
study in which consenting T2DM outpatients that meet the inclusion criteria for the
study in five tertiary health facilities were simultaneously recruited and relevant data
obtained via investigator-administered questionnaire. Data obtained which included
gender, arthropometric measures, hypoglycaemia and where it was treated were
analyzed using Statistical Package for Social Sciences (SPSS) version 23.0 software.
Results: A total of 245 T2DM outpatients were recruited into the study, made up of
107 (43.7%) male and 138 (56.3%) female. Of this, 121 (49.8%) patients were
overweight while 70 (28.7%) were obese. Among the patients, 104 (42.4%) T2DM
outpatients on insulin therapy reported hypoglycaemia which was mild in 83 (79.8%)
of the patients
Conclusion: A significant number of the type 2 DM outpatients on insulin therapy
were overweight/obese with mild hypoglycaemia in a majority of them.

References

Bonafede, M.M., Kalsekar, A., Pawaskar, M.

Ruiz MK, Torres AM et al. Insulin use and

persistence in patients with type 2 diabetes

adding mealtime insulin to a basal regimen: a

retrospective database analysis. BMC Endocr

D i s o r d 1 1 , 3 ( 2 0 1 1 ) .

https://doi.org/10.1186/1472-6823-11-3

, Koro CE, Bowlin SJ, Bourgeois N, Fedder DO.

Glycemic control from 1988 to 2000 among U.S.

adults diagnosed with type 2 diabetes: a

preliminary report. Diabetes Care. 2004

Jan;27(1):17-20. doi: 10.2337/diacare.27.1.17.

Nicasio J, Mcfarlane SI. Early insulin therapy

and the risks of cardiovascular disease in type 2

diabetes.Therapy.2005; 2(5): 685-688.

Meneghini L. Why and how to use insulin

therapy earlier in the management of type 2

diabetes. South Med J. 2007; 100(2): 164-174.

Ryan EA, Imes S, Wallace C. Short term

intensive insulin therapy in newly diagnosed type

diabetes. Diabetes care. 2004; 27(5): 1028-

Nichols GA, Koo YH, Shah SN. Delay of insulin

addition to oral combination therapy despite

inadequate glycaemic control: delay of insulin

therapy. J Gen Intern Med 2007; 22(4): 453-458.

Peyrot M, Rubin RR, Lauritzen T, Skovlund SE,

Snoek FJ, Matthews DR et al. Resistance to

insulin therapy among patients and providers:

results of the cross-national Diabetes Attitudes,

Wishes, and Needs (DAWN) study. Diabetes

Care. 2005 Nov;28(11):2673-9. doi:

2337/diacare.28.11.2673.

Caver C. Insulin treatment and the problem of

weight gain in type 2 diabetes. Diabetes Educ.

; 32(6): 910-917.

Hodism Israel, Insulin therapy, weight gain and

prognosis - A review. Diabetes, Obesity and

Metab, 2018 May: 20 (9); 2085-2092.

doi.org/10.1111/dom.13367

McCall AL. Insulin therapy and hypoglycaemia.

Endocrinol Metabol Clin North Am. 2012

March: 41(1); 57-87.

UK Prospective Diabetes Study Group. Effects of

Intensive blood glucose control with metformin

on complications in overweight patients with

type 2 diabetes (UKPDS 34) Lancet. 1998;

(9131): 854-865.

Cryer PE, Axelrod L, Grossman AB, Heller SR,

Montori VM, Seaquist ER et al. Evaluation and

management of adult hypoglycemic disorders: an

Endocrine Society Clinical Practice Guideline. J

Clin Endocrinol Metab. 2009 Mar;94(3):709-28.

doi: 10.1210/jc.2008-1410. .

Fadupin GT, Joseph EU, Keshinro OO.

Res. J. Health Sci. Vol 12(1), March 2024 4

Nkpozi et al., 2024

Prevalence of obesity in Nigeria: a case of

patients in Ibadan, Oyo state, Nigeria. Afr J Med

Med Sci 2004 Dec; 33(4): 381-384.

Gezawa ID, Uloko AE, Gwaram BA, Ibrahim

DA, Ugwu ET, Mohammed IY. Diabetes

Metabol Syndr Obes. 2019; 12: 2785-2790 doi:

2147/DMSO.S226054.

Ali YA, Almobarak AO, Awadalla H, Elmadhoun

WM, Ahmed MH. Obesity among Sudanese

adults with diabetes: a population based survey.

AnnTransl Med. 2017 Jun; 5(12): 252. doi:

2137/atm.2017.05.11

Downloads

Published

2024-02-23

How to Cite

Nkpozi, M. O., Mbah, I. O., Bozimo, G. E., Akhidue, K., Ezeude, C. M., Ogbonna, S. U., & Owolabi, F. A. (2024). Obesity and hypoglycaemia in type 2 diabetes mellitus outpatients on insulin therapy in Nigeria–data from the multicentre evaluation of type 2 diabetes mellitus outpatients patients on insulin therapy (METOIN) study. Research Journal of Health Sciences, 12(1), 1–7. Retrieved from https://rjhs.org/index.php/home/article/view/366